GE Healthcare and Preventice Solutions Collaborate to Connect the Heart, the Hospital and the Home Seamlessly

Alliance breaks down silos of information, putting a single source of triaged data into the hands of clinicians

Orlando - Feb. 12, 2019 - GE Healthcare (NYSE:GE) is working with Preventice Solutions to give clinician tools to follow patients with known or suspected Atrial fibrillation virtually from hospital to home. Atrial fibrillation, or AF, is an irregular and often rapid heart rate that can increase risk of stroke, heart failure and other heart-related complications, and, as the population ages globally, AF is predicted to affect 6 to 12 million people in the United States alone by 2050.

The collaboration offers a single vendor solution that is integrated with MUSE for seamless order-to-reporting workflow. According to U.S. News & World Reports, 24 out of 25 top U.S. cardiac hospitals use MUSE.¹ By integrating with MUSE, data from home-based patients will be made available to clinicians on the same clinical workspace they use every day.

“This development in our relationship with Preventice creates an integrated, longitudinal view of the patient experience,” said GE Healthcare Diagnostic Cardiology General Manager Ashutosh Banerjee. “We’re enabling the ECG record to grow with a richness that will allow the clinician to see how her treatment is working for the patient at home.”

‎“This partnership is transforming connected care in the industry with our customers benefiting from a ‎consistent patient experience with enhanced clinical insight,” said Preventice Solutions Chief Executive ‎Officer Jon Otterstatter. “This alliance will help standardize the operations and workflow for healthcare ‎providers resulting in improved quality.”

GE Healthcare and Preventice Solutions are announcing this latest progression of their strategic relationship at HIMSS 2019, February 12 - 15, 2019 in Orlando.